Compare MDXG & HQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | HQ |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 672.8M | 674.1M |
| IPO Year | 2007 | 2025 |
| Metric | MDXG | HQ |
|---|---|---|
| Price | $3.91 | $14.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.00 | ★ $20.50 |
| AVG Volume (30 Days) | ★ 1.5M | 89.9K |
| Earning Date | 10-28-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $418,630,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $3.03 | $8.29 |
| 52 Week High | $7.97 | $45.00 |
| Indicator | MDXG | HQ |
|---|---|---|
| Relative Strength Index (RSI) | 34.21 | 45.79 |
| Support Level | $3.76 | $13.68 |
| Resistance Level | $4.48 | $14.43 |
| Average True Range (ATR) | 0.23 | 1.11 |
| MACD | -0.04 | 0.06 |
| Stochastic Oscillator | 26.44 | 47.94 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.